• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用单克隆抗体F5对转移灶中前列腺特异性抗原进行免疫组织化学检测。

Immunohistochemical demonstration of prostate-specific antigen in metastases with the use of monoclonal antibody F5.

作者信息

Papsidero L D, Croghan G A, Asirwatham J, Gaeta J, Abenoza P, Englander L, Valenzuela L

出版信息

Am J Pathol. 1985 Dec;121(3):451-4.

PMID:2416221
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1887932/
Abstract

With the use of a murine monoclonal antibody (F5), a panel of metastatic tumors was evaluated for the expression of prostate-specific antigen (PA) under immunoperoxidase staining procedures. Specimens studied included 25 of prostatic origin and 73 originating from nonprostatic primary sites. Regardless of the site of dissemination or the malignancy grade, all metastases from the prostate were antibody-reactive. In contrast, nonprostatic metastases were negative in each case, including those originating from other genitourinary neoplasms. Thus, PA expression as detected with monoclonal antibody F5 is a stable characteristic of disseminated prostatic tumors.

摘要

使用鼠单克隆抗体(F5),在免疫过氧化物酶染色程序下评估一组转移性肿瘤中前列腺特异性抗原(PA)的表达。研究的标本包括25个前列腺来源的和73个非前列腺原发部位来源的。无论转移部位或恶性程度如何,所有前列腺转移灶均与抗体反应。相比之下,非前列腺转移灶在每种情况下均为阴性,包括那些源自其他泌尿生殖系统肿瘤的转移灶。因此,用单克隆抗体F5检测到的PA表达是播散性前列腺肿瘤的一个稳定特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5180/1887932/1062eda4fa4d/amjpathol00165-0091-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5180/1887932/9a944ee70d14/amjpathol00165-0091-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5180/1887932/b25f518fa933/amjpathol00165-0091-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5180/1887932/1062eda4fa4d/amjpathol00165-0091-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5180/1887932/9a944ee70d14/amjpathol00165-0091-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5180/1887932/b25f518fa933/amjpathol00165-0091-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5180/1887932/1062eda4fa4d/amjpathol00165-0091-c.jpg

相似文献

1
Immunohistochemical demonstration of prostate-specific antigen in metastases with the use of monoclonal antibody F5.使用单克隆抗体F5对转移灶中前列腺特异性抗原进行免疫组织化学检测。
Am J Pathol. 1985 Dec;121(3):451-4.
2
Immunohistochemical localization of prostate carcinoma-associated antigens.前列腺癌相关抗原的免疫组织化学定位
Cancer Res. 1983 Nov;43(11):5509-16.
3
[An immunohistochemical study of prostate antigen using an enzyme-labeled antibody technique].[使用酶标抗体技术对前列腺抗原进行的免疫组织化学研究]
Hinyokika Kiyo. 1983 Oct;29(10):1369-71.
4
Prostatic origin of metastases: immunoperoxidase localization of prostate-specific antigen.转移灶的前列腺起源:前列腺特异性抗原的免疫过氧化物酶定位
Urol Int. 1984;39(1):9-12. doi: 10.1159/000280934.
5
The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.P501S和前列腺特异性抗原(PSA)在前列腺转移性腺癌诊断中的作用。
Am J Surg Pathol. 2007 Sep;31(9):1351-5. doi: 10.1097/PAS.0b013e3180536678.
6
Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients.针对前列腺上皮细胞新抗原标志物及前列腺癌患者血清的单克隆抗体。
Anticancer Res. 1987 Sep-Oct;7(5B):927-35.
7
Immunohistochemical and pharmacokinetic characterization of the site-specific immunoconjugate CYT-356 derived from antiprostate monoclonal antibody 7E11-C5.源自抗前列腺单克隆抗体7E11-C5的位点特异性免疫偶联物CYT-356的免疫组织化学和药代动力学特征
Cancer Res. 1990 Oct 1;50(19):6423-9.
8
Analysis of antigenic expression by primary and autologous metastatic human sarcomas using murine monoclonal antibodies.使用鼠单克隆抗体分析原发性和自体转移性人肉瘤的抗原表达。
Cancer Res. 1984 Nov;44(11):5320-5.
9
Immunohistochemical characterization of two monoclonal antibodies, P25.48 and P25.91, which define a new prostate-specific antigen.两种单克隆抗体P25.48和P25.91的免疫组织化学特征,这两种抗体定义了一种新的前列腺特异性抗原。
Cancer Res. 1988 Dec 1;48(23):6938-42.
10
Characterization of a monoclonal antibody, KR-P8, that detects a new prostate-specific marker.
J Natl Cancer Inst. 1984 Sep;73(3):617-25.

引用本文的文献

1
A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary using circulating tumor cells.一种基于多重标志物的算法,用于利用循环肿瘤细胞诊断原发灶不明的癌症。
Oncotarget. 2016 Jan 26;7(4):3662-76. doi: 10.18632/oncotarget.6657.
2
Cerebral metastases as first symptom of cancer: a clinico-pathologic study.脑转移作为癌症的首发症状:一项临床病理研究。
J Neurooncol. 2000 Dec;50(3):265-73. doi: 10.1023/a:1006413001375.
3
Expression of Zn-alpha 2-glycoprotein and PSP-94 in prostatic adenocarcinoma. An immunohistochemical study of 88 cases.

本文引用的文献

1
A prostate antigen in sera of prostatic cancer patients.前列腺癌患者血清中的一种前列腺抗原。
Cancer Res. 1980 Jul;40(7):2428-32.
2
Prostate antigen: a marker for human prostate epithelial cells.前列腺抗原:一种人类前列腺上皮细胞的标志物。
J Natl Cancer Inst. 1981 Jan;66(1):37-42.
3
Evaluation of prostate specific acid phosphatase and prostate specific antigen in identification of prostatic cancer.
J Urol. 1983 Feb;129(2):315-8. doi: 10.1016/s0022-5347(17)52074-1.
锌α2糖蛋白和前列腺分泌蛋白-94在前列腺腺癌中的表达。88例免疫组织化学研究。
Am J Pathol. 1990 May;136(5):1147-52.
4
Monoclonal antibody (F5) to human prostate antigen.针对人类前列腺抗原的单克隆抗体(F5)
Hybridoma. 1983;2(2):139-47. doi: 10.1089/hyb.1983.2.139.
5
Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate.前列腺良性增生和腺癌中的多种免疫过氧化物酶标志物
Am J Clin Pathol. 1984 Mar;81(3):279-84. doi: 10.1093/ajcp/81.3.279.
6
Immunohistologic diagnosis of 2 cases of metastatic prostate cancer to breast.2例前列腺癌乳腺转移的免疫组织学诊断
J Urol. 1983 Aug;130(2):365-7. doi: 10.1016/s0022-5347(17)51153-2.
7
Immunoperoxidase localization of prostate-specific antigen.前列腺特异性抗原的免疫过氧化物酶定位
Am J Surg Pathol. 1982 Sep;6(6):553-7. doi: 10.1097/00000478-198209000-00007.
8
Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms.前列腺特异性抗原:前列腺肿瘤的一种免疫组织学标志物。
Cancer. 1981 Sep 1;48(5):1229-32. doi: 10.1002/1097-0142(19810901)48:5<1229::aid-cncr2820480529>3.0.co;2-l.
9
Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay.用灵敏的酶免疫测定法对血清中前列腺特异性抗原进行定量分析。
Cancer Res. 1980 Dec;40(12):4658-62.
10
Prognostic importance of prostate-specific antigen for monitoring patients with stages B2 to D1 prostate cancer.前列腺特异性抗原在监测B2至D1期前列腺癌患者中的预后重要性。
Cancer Res. 1985 Feb;45(2):886-91.